Transjugular intrahepatic portosystemic shunt creation using intravascular ultrasound vs fluoroscopic guidance: A dual-institution retrospective comparative study

Table 2 Post-procedure laboratory marker adverse events at one month, n (%)

Laboratory marker CTCAE grade1	cTIPS	iTIPS	P value
AST2	n = 109	n = 52	0.08
0	74 (68)	44 (85)	-
1	33 (30)	8 (15)	-
2	1 (1)	0 (0)	-
3	0 (0)	0 (0)	-
4	1 (1)	0 (0)	-
ALT3	n = 109	n = 53	0.18
0	102 (94)	53 (100)	-
1	6 (5)	0 (0)	-
2	0 (0)	0 (0)	-
3	1 (1)	0 (0)	-
4	0 (0)	0 (0)	-
Total bilirubin4	n = 109	n = 53	0.82
0	37 (34)	19 (36)	-
1	37 (34)	14 (26)	-
2	24 (22)	14 (26)	-
3	10 (9)	5 (9)	-
4	1 (1)	1 (2)	-
INR	n = 109	n = 53	1
< 2 × BL	109 (100)	53 (100)	-
> 2 × BL	0 (0)	0 (0)	-

¹Uses upper limit of normal if baseline is normal, or baseline if baseline is abnormal.

²The upper limit of normal was 41.

³The upper limit of normal was 63 in men and 54 in women.

⁴The upper limit of normal was 1.2.

P values were obtained using Fisher exact test. cTIPS: Conventional fluoroscopic-guided transjugular intrahepatic portosystemic shunt; iTIPS: Intravascular ultrasound-guided transjugular intrahepatic portosystemic shunt; CTCAE: Common Terminology Criteria for Adverse Events; AST: Aspartate transaminase; ALT: Alanine transaminase; UNL: Upper limit of normal; BL: Baseline; INR: International normalized ratio.